• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳曲酮治疗成瘾的医疗保健专业人员:一项合作私人执业经验。

Naltrexone treatment for addicted health-care professionals: a collaborative private practice experience.

作者信息

Ling W, Wesson D R

出版信息

J Clin Psychiatry. 1984 Sep;45(9 Pt 2):46-8.

PMID:6469936
Abstract

Sixty physicians and other health-care professionals with narcotic dependency were treated with naltrexone, 300 to 350 mg/week, in private physicians' offices. Patients remained on naltrexone treatment for an average of 8 months. On a global scale rating the degree of improvement in drug abuse, professional activities, and psychosocial adjustment, 29 patients were rated much improved and 31 either moderately or slightly improved. When these two groups were compared, it was found that more patients in the much improved group did not drink (p less than .01) and remained in naltrexone treatment longer than 6 months (p less than .01). Patients in the much improved group were also older (p less than .01). Naltrexone, used in the private practice setting, appears to be a useful treatment adjunct for addicted health-care professionals.

摘要

60名有麻醉品依赖问题的医生和其他医疗保健专业人员在私人医生诊所接受了纳曲酮治疗,剂量为每周300至350毫克。患者接受纳曲酮治疗的平均时间为8个月。在对药物滥用、专业活动和心理社会适应方面的改善程度进行总体评分时,29名患者被评为改善显著,31名患者被评为中度或轻度改善。比较这两组时发现,改善显著组中更多患者不饮酒(p小于0.01),且接受纳曲酮治疗的时间超过6个月(p小于0.01)。改善显著组的患者年龄也更大(p小于0.01)。在私人执业环境中使用的纳曲酮似乎是治疗成瘾医疗保健专业人员的一种有用辅助药物。

相似文献

1
Naltrexone treatment for addicted health-care professionals: a collaborative private practice experience.纳曲酮治疗成瘾的医疗保健专业人员:一项合作私人执业经验。
J Clin Psychiatry. 1984 Sep;45(9 Pt 2):46-8.
2
Naltrexone in addicted business executives and physicians.
J Clin Psychiatry. 1984 Sep;45(9 Pt 2):39-41.
3
Naltrexone treatment in a jail work-release program.在监狱工作释放计划中使用纳曲酮治疗。
J Clin Psychiatry. 1984 Sep;45(9 Pt 2):49-52.
4
The role of the National Institute on Drug Abuse in the development of naltrexone.美国国家药物滥用研究所(National Institute on Drug Abuse)在纳曲酮研发中的作用。
J Clin Psychiatry. 1984 Sep;45(9 Pt 2):4-6.
5
Clinical experience with naltrexone in suburban opioid addicts.纳曲酮在郊区阿片类药物成瘾者中的临床经验。
J Clin Psychiatry. 1984 Sep;45(9 Pt 2):42-5.
6
Naltrexone: a clinical perspective.纳曲酮:临床视角
J Clin Psychiatry. 1984 Sep;45(9 Pt 2):25-8.
7
Treating opioid addiction with buprenorphine-naloxone in community-based primary care settings.在社区基层医疗环境中使用丁丙诺啡-纳洛酮治疗阿片类药物成瘾。
Ann Fam Med. 2007 Mar-Apr;5(2):146-50. doi: 10.1370/afm.665.
8
Naltrexone in addicted physicians and business executives.
NIDA Res Monogr. 1984;55:185-90.
9
[Ultra-rapid detoxification of opiate dependent patients: review of the literature, critiques and proposition for an experimental protocol].[阿片类药物依赖患者的超快速脱毒:文献综述、批判及实验方案建议]
Encephale. 2001 Mar-Apr;27(2):187-93.
10
[Naltrexone and prevention of opiate dependence relapse. An Italian experience].
Minerva Psichiatr. 1989 Apr-Jun;30(2):93-8.

引用本文的文献

1
Slow-release naltrexone implant versus oral naltrexone for improving treatment outcomes in people with HIV who are addicted to opioids: a double-blind, placebo-controlled, randomised trial.长效纳曲酮植入剂与口服纳曲酮治疗阿片类物质成瘾的 HIV 感染者:一项双盲、安慰剂对照、随机试验。
Lancet HIV. 2019 Apr;6(4):e221-e229. doi: 10.1016/S2352-3018(18)30362-X. Epub 2019 Mar 14.
2
Antagonists in the medical management of opioid use disorders: Historical and existing treatment strategies.阿片类物质使用障碍医学管理中的拮抗剂:历史和现有治疗策略。
Am J Addict. 2018 Apr;27(3):177-187. doi: 10.1111/ajad.12711.
3
Effects of incentives for naltrexone adherence on opiate abstinence in heroin-dependent adults.
纳曲酮依从性激励措施对海洛因依赖成年人阿片类物质戒断的影响。
Addiction. 2017 May;112(5):830-837. doi: 10.1111/add.13724. Epub 2017 Feb 3.
4
Selective review and commentary on emerging pharmacotherapies for opioid addiction.对阿片类药物成瘾新兴药物疗法的选择性综述与评论。
Subst Abuse Rehabil. 2011 Oct 28;2:181-8. doi: 10.2147/SAR.S22782. eCollection 2011.
5
Epidemiologic and molecular pathophysiology of chronic opioid dependence and the place of naltrexone extended-release formulations in its clinical management.慢性阿片类药物依赖的流行病学及分子病理生理学,以及纳曲酮缓释制剂在其临床管理中的地位。
Subst Abuse. 2012;6:115-33. doi: 10.4137/SART.S9031. Epub 2012 Sep 27.
6
Maintenance medication for opiate addiction: the foundation of recovery.阿片类药物成瘾维持治疗药物:康复的基础。
J Addict Dis. 2012;31(3):207-25. doi: 10.1080/10550887.2012.694598.
7
Current and potential pharmacological treatment options for maintenance therapy in opioid-dependent individuals.阿片类物质依赖者维持治疗的现有和潜在药物治疗选择。
Drugs. 2012 Jan 22;72(2):217-28. doi: 10.2165/11597520-000000000-00000.
8
Oral naltrexone maintenance treatment for opioid dependence.口服纳曲酮维持治疗阿片类物质依赖。
Cochrane Database Syst Rev. 2011 Apr 13;2011(4):CD001333. doi: 10.1002/14651858.CD001333.pub4.
9
(R)-methadone versus racemic methadone: what is best for patient care?(R)-美沙酮与外消旋美沙酮:哪一种更适合患者治疗?
Addiction. 2011 Apr;106(4):687-8. doi: 10.1111/j.1360-0443.2011.03374.x.
10
A randomized trial of oral naltrexone for treating opioid-dependent offenders.口服纳曲酮治疗阿片类药物依赖罪犯的随机试验。
Am J Addict. 2010 Sep-Oct;19(5):422-32. doi: 10.1111/j.1521-0391.2010.00070.x.